Epstein-Barr virus-mediated transformation of B cells induces global chromatin changes independent to the acquisition of proliferation

Nucleic Acids Research

Volumn 42, Issue 1, 2014, Pages 249-263

  Hernando, Henar ^a   Islam, Abul B M M K ^b,c   Rodríguez Ubreva, Javier ^a   Forné, Ignasi ^d   Ciudad, Laura ^a   Imhof, Axel ^d   Shannon Lowe, Claire ^e   Ballestar, Esteban ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c UNIVERSITY OF DHAKA   (Bangladesh)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; DEOXYRIBONUCLEASE; HISTONE H3; HISTONE H4; INTERLEUKIN 4; ENDONUCLEASE; EPSTEIN BARR VIRUS ANTIGEN 2;

ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS INFECTION; GENE CLUSTER; HETEROCHROMATIN; HISTONE MODIFICATION; HOX GENE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION; VIRUS CELL TRANSFORMATION; ZNF GENE; B LYMPHOBLAST; B LYMPHOCYTE ACTIVATION; CONSTITUTIVE HETEROCHROMATIN; EPSTEIN BARR VIRUS; NONHUMAN;

EID: 84891771044     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt886     Document Type: Article

References (45)

1. Francastel, C., Schubeler, D., Martin, D.I. and Groudine, M. (2000) Nuclear compartmentalization and gene activity. Nat. Rev. Mol. Cell Biol., 1, 137-143
2. Trojer, P. and Reinberg, D. (2007) Facultative heterochromatin: Is there a distinctive molecular signaturëMol. Cell, 28, 1-13
3. Hollyoake, M., Stuhler, A., Farrell, P., Gordon, J. and Sinclair, A. (1995) The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus. Cancer Res., 55, 4784-4787
4. Shaffer, A.L. III, Young, R.M. and Staudt, L.M. (2012) Pathogenesis of human B cell lymphomas. Annu. Rev. Immunol., 30, 565-610
5. Magrath, I. (2012) Epidemiology: Clues to the pathogenesis of Burkitt lymphoma. Br. J. Haematol., 156, 744-756
6. Saha, A. and Robertson, E.S. (2011) Epstein-Barr virus-Associated B-cell lymphomas: Pathogenesis and clinical outcomes. Clin. Cancer Res., 17, 3056-3063
7. Pender, M.P. (2003) Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol., 24, 584-588
8. Kaye, K.M., Izumi, K.M. and Kieff, E. (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl Acad. Sci. USA, 90, 9150-9154
9. Kilger, E., Kieser, A., Baumann, M. and Hammerschmidt, W. (1998) Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J., 17, 1700-1709
10. Jayachandra, S., Low, K.G., Thlick, A.E., Yu, J., Ling, P.D., Chang, Y. and Moore, P.S. (1999) Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. Proc. Natl Acad. Sci. USA, 96, 11566-11571
11. Wang, L., Grossman, S.R. and Kieff, E. (2000) Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc. Natl Acad. Sci. USA, 97, 430-435
12. Delecluse, H.J., Hilsendegen, T., Pich, D., Zeidler, R. and Hammerschmidt, W. (1998) Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl Acad. Sci. USA, 95, 8245-8250
13. Feederle, R., Bartlett, E.J. and Delecluse, H.J. (2010) Epstein-Barr virus genetics: Talking about the BAC generation. Herpesviridae, 1, 6
14. Caballero, R., Setien, F., Lopez-Serra, L., Boix-Chornet, M., Fraga, M.F., Ropero, S., Megias, D., Alaminos, M., Sanchez- Tapia, E.M., Montoya, M.C. et al. (2007) Combinatorial effects of splice variants modulate function of Aiolos. J. Cell Sci., 120, 2619-2630
15. Jasencakova, Z., Scharf, A.N., Ask, K., Corpet, A., Imhof, A., Almouzni, G. and Groth, A. (2010) Replication stress interferes with histone recycling and predeposition marking of new histones. Mol. Cell, 37, 736-743
16. Ballestar, E., Paz, M.F., Valle, L., Wei, S., Fraga, M.F., Espada, J., Cigudosa, J.C., Huang, T.H. and Esteller, M. (2003) Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J., 22, 6335-6345
17. Min, J.L., Barrett, A., Watts, T., Pettersson, F.H., Lockstone, H.E., Lindgren, C.M., Taylor, J.M., Allen, M., Zondervan, K.T. and McCarthy, M.I. (2010) Variability of gene expression profiles in human blood and lymphoblastoid cell lines. BMC Genomics, 11, 96
18. Hubbard, T.J., Aken, B.L., Beal, K., Ballester, B., Caccamo, M., Chen, Y., Clarke, L., Coates, G., Cunningham, F., Cutts, T. et al. (2007) Ensembl 2007. Nucleic Acids Res., 35, D610-D617
19. Quinlan, A.R. and Hall, I.M. BEDTools: A flexible suite of utilities for comparing genomic features. Bioinformatics, 26, 841-842
20. Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum, C., Myers, R.M., Brown, M., Li, W. et al. (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol., 9, R137
21. Zang, C., Schones, D.E., Zeng, C., Cui, K., Zhao, K. and Peng, W. (2009) A clustering approach for identification of enriched domains from histone modification ChIP-Seq data. Bioinformatics, 25, 1952-1958
22. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T. et al. (2000) Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 25, 25-29
23. Perez-Llamas, C. and Lopez-Bigas, N. (2011) Gitools: Analysis and visualisation of genomic data using interactive heat-maps. PLoS ONE, 6, e19541
24. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser., 57, 289-300
25. Anderton, J.A., Bose, S., Vockerodt, M., Vrzalikova, K., Wei, W., Kuo, M., Helin, K., Christensen, J., Rowe, M., Murray, P.G. et al. (2011) The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma. Oncogene, 30, 2037-2043
26. Morin, R.D., Johnson, N.A., Severson, T.M., Mungall, A.J., An, J., Goya, R., Paul, J.E., Boyle, M., Woolcock, B.W., Kuchenbauer, F. et al. (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat. Genet., 42, 181-185
27. Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R.S. and Zhang, Y. (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science, 298, 1039-1043
28. O'Geen, H., Squazzo, S.L., Iyengar, S., Blahnik, K., Rinn, J.L., Chang, H.Y., Green, R. and Farnham, P.J. (2007) Genome-wide analysis of KAP1 binding suggests autoregulation of KRAB-ZNFs. PLoS Genet., 3, e89
29. Fournier, A., McLeer-Florin, A., Lefebvre, C., Duley, S., Barki, L., Ribeyron, J., Alboukadel, K., Hamaidia, S., Granjon, A., Gressin, R. et al. (2010) 1q12 chromosome translocations form aberrant heterochromatic foci associated with changes in nuclear architecture and gene expression in B cell lymphoma. EMBO Mol. Med., 2, 159-171
30. Fraga, M.F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K. et al. (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet., 37, 391-400
31. Gonzalo, S., Garcia-Cao, M., Fraga, M.F., Schotta, G., Peters, A.H., Cotter, S.E., Eguia, R., Dean, D.C., Esteller, M., Jenuwein, T. et al. (2005) Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat. Cell Biol., 7, 420-428
32. Jochner, N., Eick, D., Zimber-Strobl, U., Pawlita, M., Bornkamm, G.W. and Kempkes, B. (1996) Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: Implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells. EMBO J., 15, 375-382
33. Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E. and Rickinson, A. (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell, 65, 1107-1115
34. Hernando, H., Shannon-Lowe, C., Islam, A.B.M.M.K., Al-Shahrour, F., Rodríguez-Ubreva, J., Rodríguez-Cortez, V.C., Javierre, B.M., Mangas, C., Fernandez, A.F., Parra, M. et al. (2013) The B cell transcription program mediates hypomethylation and overexpression of key genes in Epstein-Barr virus-Associated proliferative conversion. Genome Biol., 14, R3
35. Gilbert, N., Thomson, I., Boyle, S., Allan, J., Ramsahoye, B. and Bickmore, W.A. (2007) DNA methylation affects nuclear organization, histone modifications, and linker histone binding but not chromatin compaction. J. Cell Biol., 177, 401-411
36. Dutton, A., Woodman, C.B., Chukwuma, M.B., Last, J.I., Wei, W., Vockerodt, M., Baumforth, K.R., Flavell, J.R., Rowe, M., Taylor, A.M. et al. (2007) Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells. Blood, 109, 2597-2603
37. Sarkari, F., Sanchez-Alcaraz, T., Wang, S., Holowaty, M.N., Sheng, Y. and Frappier, L. (2009) EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS Pathog., 5, e1000624
38. Jourdan, N., Jobart-Malfait, A., Dos Reis, G., Quignon, F., Piolot, T., Klein, C., Tramier, M., Coppey-Moisan, M. and Marechal, V. (2012) Live-cell imaging reveals multiple interactions between Epstein-Barr virus nuclear antigen 1 and cellular chromatin during interphase and mitosis. J. Virol., 86, 5314-5329
39. Coppotelli, G., Mughal, N., Callegari, S., Sompallae, R., Caja, L., Luijsterburg, M.S., Dantuma, N.P., Moustakas, A. and Masucci, M.G. The Epstein-Barr virus nuclear antigen-1 reprograms transcription by mimicry of high mobility group A proteins. Nucleic Acids Res., 41, 2950-2962
40. Stuber, G., Mattsson, K., Flaberg, E., Kati, E., Markasz, L., Sheldon, J.A., Klein, G., Schulz, T.F. and Szekely, L. (2007) HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus. Mol. Cancer, 6, 28
41. Mughal, N., Coppotelli, G., Callegari, S., Gastaldello, S. and Masucci, M.G. (2013) Interaction of gamma-herpesvirus genome maintenance proteins with cellular chromatin. PLoS ONE, 8, e62783
42. Grigoryev, S.A., Nikitina, T., Pehrson, J.R., Singh, P.B. and Woodcock, C.L. (2004) Dynamic relocation of epigenetic chromatin markers reveals an active role of constitutive heterochromatin in the transition from proliferation to quiescence. J. Cell Sci., 117, 6153-6162
43. Muller-Tidow, C., Klein, H.U., Hascher, A., Isken, F., Tickenbrock, L., Thoennissen, N., Agrawal-Singh, S., Tschanter, P., Disselhoff, C., Wang, Y. et al. (2010) Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia. Blood, 116, 3564-3571
44. Kwon, M.J., Kim, S.S., Choi, Y.L., Jung, H.S., Balch, C., Kim, S.H., Song, Y.S., Marquez, V.E., Nephew, K.P. and Shin, Y.K. (2010) Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications. Carcinogenesis, 31, 974-983
45. Wei, Y., Xia, W., Zhang, Z., Liu, J., Wang, H., Adsay, N.V., Albarracin, C., Yu, D., Abbruzzese, J.L., Mills, G.B. et al. (2008) Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol. Carcinog., 47, 701-706